GreenLight Clinical Revenue and Competitors

Sydney, AUS

Location

N/A

Total Funding

Research

Industry

Estimated Revenue & Valuation

  • GreenLight Clinical's estimated annual revenue is currently $5.4M per year.(i)
  • GreenLight Clinical's estimated revenue per employee is $91,800

Employee Data

  • GreenLight Clinical has 59 Employees.(i)
  • GreenLight Clinical grew their employee count by -8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$10.6M10414%N/AN/A
#2
$27.2M2424%N/AN/A
#3
$5.2M5719%N/AN/A
#4
$5.4M59-8%N/AN/A
#5
$0.2M3N/AN/AN/A
#6
$11.8M116-21%N/AN/A
#7
$19.3M172N/AN/AN/A
#8
$16.9M1513%N/AN/A
#9
$31.4M2804%N/AN/A
#10
$44.5M3494%N/AN/A
Add Company

GreenLight Clinical is a full-service Contract Research Organisation (CRO) with headquarters in Sydney, Australia. GreenLight Clinical can provide all services required to take your product from bench-top to bedside and beyond. These include, amongst others, trial design, study management and monitoring, drug safety and pharmacovigilance, statistics, site selection, human research ethics committee (HREC) submissions, regulatory compliance, monitoring and reporting. We can also provide and host customised data management services including Electronic Data Capture (EDC). All of these services can be tailored to meet your expectations. GreenLight Clinical?s mission is to speed up the global development of safe and effective drugs while guaranteeing high standards of quality and ethics in clinical research. Our experienced team of specialists can help you find the right patients and the right sites to support smooth completion of your global trials. Please refer to our website: www.greenlightclinical.com for more information.

keywords:N/A

N/A

Total Funding

59

Number of Employees

$5.4M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GreenLight Clinical News

2022-04-17 - Hong Kong approves trials for 3 Chinese vaccines targeting Omicron variant

Hong Kong has given the green light for clinical trials to begin on three new Covid-19 vaccines manufactured by mainland Chinese companies...

2022-04-17 - Digital twin generator Unlearn nets $50M to bolster clinical trials with ...

“Unlearn has proven how generative AI-models trained on clinical data can ... so tests will be ready to launch alongside an FDA green light,...

2022-04-06 - CanSinoBIO's mRNA vaccine gets green light for clinical trials in China

- Chinese vaccine developer CanSino Biologics Inc (CanSinoBIO) has received authorization to start clinical trials of its messenger RNA (mRNA)...

2019-09-08 - CytoDyn wins FDA approval for Phase 2 Study of leronlimab and Regorafenib as combo therapy

... Drug Administration has given the greenlight to its Phase 2 protocol for ... “This is the third clinical program that CytoDyn has underway in the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.7M5926%N/A
#2
$12.1M599%N/A
#3
$12.1M5913%N/A
#4
$7.7M5911%N/A
#5
$12.9M5934%N/A